West Nile Cases Hit Fastest Season Start Since 2004 as Peak Weeks Begin
Forty-eight human cases were reported by June 30, about five times the usual figure, and counts reached 143 through August 4, per CDC-based data.
Health News
Health News covers regulatory and clinical developments as they are issued: approvals, recalls, safety communications and guideline revisions. Each report names the issuing authority, describes who is affected, and states what action a reader should take. Filed quickly, and corrected openly whenever facts change.
Drug approvals, product recalls, safety advisories and revised clinical guidance, written so a reader knows immediately whether it applies to them.
US Measles Count Passes 2,400 as Outbreaks Enter a Second Record Year
CDC surveillance recorded 2,465 confirmed cases by August 6, with 94 percent tied to outbreaks and hospitalization in about 7 percent of cases.
CDC Alert Documents 1,645 Confirmed Cases in Multistate Cyclospora Outbreak
A July 14 health notice tied the seasonal surge to 34 states and 141 hospitalizations, with a food source still under FDA investigation.
FDA Approves Simtriyo, a First-in-Class Nonstimulant Pill for ADHD
Otsuka's centanafadine, the first approved norepinephrine, dopamine, and serotonin reuptake inhibitor, is cleared for patients 6 and older.
FDA Approves Zidesamtinib for ROS1-Positive Lung Cancer After Progression
The agency cleared Jideytro on July 22, 2026 for patients whose ROS1-positive non-small cell lung cancer advanced on a prior ROS1 inhibitor.
FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
Merck's once-daily Lipfendra (enlicitide) cut LDL cholesterol by nearly 60 percent in trials and offers an alternative to injections.